Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
VTX-1463 | VTX-1463 | Phase 1 Clinical | Ventirx | Rhinitis, Allergic | Details |
CB-06 | CB 06036; CB-06 | Phase 1 Clinical | Shanghai Zhimeng Biopharma Inc | Hepatitis B | Details |
Bazlitoran | IMO-8400 | Idera | Details | ||
HRS-9950 | HRS-9950 | Phase 1 Clinical | Jiangsu Hengrui Medicine Co Ltd, Suzhou Suncadia Biopharmaceuticals Co Ltd, Shanghai Hengrui Pharmaceutical Co Ltd | Hepatitis B, Chronic | Details |
BDC-1001 | BDC-1001 | Phase 2 Clinical | Bolt Biotherapeutics Inc | Solid tumours | Details |
CV-8102 | CV-8102 | Phase 1 Clinical | Curevac Ag | Squamous Cell Carcinoma of Head and Neck; Skin Neoplasms; Carcinoma, Adenoid Cystic; Rabies; Carcinoma, Squamous Cell; Carcinoma, Hepatocellular; Melanoma | Details |
Motolimod | VTX-378; VTX-2337 | Phase 1 Clinical | Array Biopharma, Celgene Corp | Salivary Gland Neoplasms; Tongue Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Endometrioid; Melanoma; Carcinoma, Squamous Cell; Lymphoma; Paranasal Sinus Neoplasms; Laryngeal Neoplasms; Fallopian Tube Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Breast Neoplasms; Cystadenocarcinoma; Carcinoma, Verrucous; Pancreatic Neoplasms; Carcinoma, Ovarian Epithelial; Squamous Cell Carcinoma of Head and Neck; Cystadenocarcinoma, Serous; Cystadenocarcinoma, Mucinous; Carcinoma, Renal Cell; Lymphoma, B-Cell; Ovarian Neoplasms; Solid tumours; Brenner Tumor | Details |
Enpatoran | M-5049 | Phase 2 Clinical | Merck & Co Inc | Lupus Erythematosus, Cutaneous; Coronavirus Disease 2019 (COVID-19); Lupus Erythematosus, Systemic | Details |
TransCon-TLR-7/8-agonist | Phase 2 Clinical | Ascendis Pharma Oncology Division As | Solid tumours; Papillomavirus Infections; Neoplasm Metastasis | Details | |
Afimetoran | BMS-986256 | Phase 2 Clinical | Bristol-Myers Squibb Company | Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic | Details |
E-6742 | E-6742 | Phase 2 Clinical | Eisai Co Ltd | Lupus Erythematosus, Systemic | Details |
DN-1508052 | DN-1508052; DN1508052-01 | Phase 2 Clinical | Shanghai De Novo Pharmatech Co Ltd | Solid tumours; Neoplasms | Details |
BDB-018 | BDB-018 | Phase 1 Clinical | Seven And Eight Biopharmaceuticals Inc | Solid tumours | Details |
Selgantolimod | GS-9688 | Phase 2 Clinical | Gilead Inc | HIV Infections; Hepatitis B, Chronic; Hepatitis B | Details |
This web search service is supported by Google Inc.